Jyoti D. Patel, MD, thoracic oncologist, Northwestern University Feinberg School of Medicine, discusses the benefits of multidisciplinary approach for the treatment of patients with stage III disease.

All patients with stage III disease will receive chemotherapy, Patel says, and their medical oncologist will guide them through the process. There needs to be a conversation with a radiation oncologist regarding heart and lung toxicity and a conversation with a surgeon regarding resection.

View more from the 2014 Multidisciplinary Symposium in Thoracic Oncology

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


Lung Cancer

JAN-22-OSD1275 - /clinical/lung-cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Dr. Patel on the Benefits of a Multidisciplinary Approach for Patients With Stage III Lung Cancer